Decibel Appoints Paul Wilson as CEO

June 22nd, 2021 - Ryan Allway

CALGARY, AB, June 22, 2021 /PRNewswire/ – Decibel Cannabis Company Inc. (the “Company” or “Decibel”) (TSXV: DB) (OTCQB: DBCCF), a premium cannabis producer, is pleased to announce  the appointment of Paul Wilson as its Chief Executive Officer, effective Wednesday, June 23rd. Emphasizing the Company’s objective for brand growth, Mr. Wilson brings CEO and President level experience from some of Canada’s top consumer brands […]

Phyto Extractions Announces Michael Forbes as New CEO

May 10th, 2021 - Ryan Allway

LANGLEY, BC / ACCESSWIRE / May 10, 2021 / Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE:XTRX)(Frankfurt:D2EP) (“Phyto Extractions” or the “Company”) is proud to announce Michael Forbes Pharm, MBA as its new CEO and director.   Mr. Forbes comes to Phyto Extractions with a background firmly rooted in medicine, cannabis production and entrepreneurship. Demonstrating […]

Microdosing: The Next Revolution in Psychedelics

April 22nd, 2021 - Ryan Allway

The psychedelics industry has experienced a renaissance over the past few years as researchers have opened a pandora’s box of potential. From major depression to generalized anxiety to post-traumatic stress disorder, emerging research suggests that psychedelic substances could have a significant beneficial impact on hard-to-treat mental health disorders. As states liberalize their psychedelics regulations, microdosing […]

Silo Pharma: A Capital Efficient Strategy Targeting Psychedelics

February 23rd, 2021 - Ryan Allway

Psychedelics have the potential to revolutionize mental health disorders that have been woefully underserved by conventional therapies. According to Data Bridge Market Research, psychedelic drug sales will grow from just over $2 billion in 2019 to over $6.8 billion by 2027, which represents a 16.3% compound annual growth rate. Investors have many different options for […]

Psychedelics: Significant Investor Interest Despite the Pandemic

February 16th, 2021 - Ryan Allway

  The COVID-19 pandemic may be ravaging large swaths of the economy, but the stock market has consistently hit new record highs. After spending several years under-the-radar, the psychedelics industry is experiencing a renaissance driven by a combination of FDA-driven catalysts and soaring investor interest in a new class of potential blockbuster therapeutics.  Let’s take […]

How to Invest in Cannabis Delivery

January 18th, 2021 - Ryan Allway

Delivery services of all kinds experienced record-breaking growth in 2020 thanks to a global pandemic that has depressed retailers, restaurants, and grocery stores. Of course, these trends are just an acceleration of an existing transition from brick-and-mortar to e-commerce—a trend that many in the cannabis industry are betting will be transformative. Let’s take a look […]

Cardiol Therapeutics’ Cortalex™ CBD Now Available Exclusively Online at Medical Cannabis by Shoppers Inc.

October 20th, 2020 - Ryan Allway

The first pharmaceutically produced THC-free* extra-strength cannabidiol (CBD) Oakville, Ontario–(Newsfile Corp. – October 20, 2020) –  Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) (“Cardiol” or the “Company“), a clinical-stage biotechnology company focused on developing innovative therapies for inflammatory heart disease, is pleased to announce the commercial introduction of CortalexTM, a THC-free* extra-strength (100 mg/mL concentration) oral […]

Israel Gives Final Go-Ahead for Cannabis Exports: Here’s Who Could Profit

June 5th, 2020 - Ryan Allway

Israel gave final approval in mid-May for exports of medical cannabis, paving the way for more than one billion shekels ($273 million) in annual revenue. The country will become one of just three countries that have approved the export of medical cannabis to countries that permit its use—after Canada and the Netherlands— when the law […]

THC BioMed Reports Growing Revenue & Profitability

April 22nd, 2020 - Ryan Allway

Cannabis investors had already been shifting from “unproven potential” to “profitability” over the past several quarters prior to the global health crisis. With the COVID-19 outbreak, investors have fled previous investments to profitable companies that aren’t reliant on costly or dilutive funding to sustain their operations. THC BioMed Intl Ltd. (CSE: THC) recently recorded its […]

Science-driven Brand Delivers 5 Perfected Cannabis Highs

April 6th, 2020 - Robin Lefferts

What happens when the investment environment surrounding cannabis companies evaporates amid concerns about overvaluations and lack of returns? And then, a worldwide pandemic reverses years of economic growth almost overnight, plunging economies into near-instant depression? One thing that happens is some quality companies become distressed, offering investors the opportunity to purchase a stake at a […]

Psychedelics: Investing in the Perfect BrainStorm

April 6th, 2020 - Ryan Allway

Psychedelics are rapidly becoming both a mainstream treatment option and investment opportunity. With growing interest among researchers, forward-thinking companies are starting to build a presence in the space.  In this article, we will take a look at the growing body of therapeutic evidence for psychedelics. How decriminalization is gaining ground, and how Ehave Inc. (OTC: […]

Cannabis Brands Want Their Own Store, CalEthos Deems it Essential

April 3rd, 2020 - Robin Lefferts

Cannabis Shelf Space Deemed Essential What is the ideal setting for a brand to showcase its wares to the retail consumer? It is certainly not a crowded store with hundreds of brands competing for limited shelf space and consumer attention. Every brand out there would much rather have its own store, featuring its own product […]

Coping With Stress During the COVID-19 Outbreak with CBD & Adaptogens

April 2nd, 2020 - Ryan Allway

The COVID-19 outbreak has become a major source of stress over the past several weeks. In addition to the fear and anxiety of disease, quarantines and “stay at home” orders have contributed to stress levels, leading to poor sleep, unhealthy eating, and other side-effects. It’s important for everyone to take inventory of their health and […]

Israel Begins Cannabis Exports to Meet Unmet Medical Needs

March 30th, 2020 - Ryan Allway

Israel has long been an international center for cannabis research. THC, the psychoactive ingredient in cannabis, and CBD, the plant’s predominant non-psychoactive ingredient, were first isolated and defined by Israeli researcher Dr. Raphael Mechoulam in the early 1960s. Research continued there in the following decades, and the Israeli government has contributed greatly to the country’s […]

CannaTrac’s Diversified Revenue Streams Create a Baseline for Consistent, Sustainable Growth

March 25th, 2020 - Ryan Allway

The legal cannabis industry has had its ups and downs since its inception just a few years ago. Legislation and licensing decisions helped boost some companies, while overcapacity and regulatory issues depressed others. The best companies have found ways to diversify their revenue streams to generate consistent and sustainable growth over time.  In this article, […]

Isracann Enters JV for Near-Term Cannabis Farm Production Opportunity in Israel

March 24th, 2020 - Ryan Allway

24 MAR 2020 / CORPORATE NEWS Partnership advances time-to-market to under six months VANCOUVER, BC, — (March 24, 2020) – Isracann Biosciences Inc.  (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for both domestic and European export sales, is […]

Adaptogens, Functional Beverages, and CBD

March 16th, 2020 - Ryan Allway

It’s a stressful world out there, and consumers know it. In growing numbers, people are looking for healthy foods, naturally sourced, to keep both themselves and the planet on a positive track. If those foods can also relieve stress and help people relax, all the better. Beverages are a prime example of the trend toward […]

Psychedelics, the Next Frontier in Drug Research

March 1st, 2020 - Ryan Allway

A big factor in the recent rise of cannabis legalization is the emergence of legitimate scientific research into the potential health benefits of the plant’s active ingredients, called cannabinoids. Medicines are often derived from naturally occurring compounds, from aspirin to insulin to penicillin. A decent body of research is currently pointing to psilocybin, the psychedelic […]

Supreme Cannabis Focuses Organization and Reduces Cost Structure to Accelerate Profitable Growth

February 11th, 2020 - Ryan Allway

Corporate positions decreased by approximately 33% and operational positions decreased by approximately 13% Total number of positions decreased by approximately 15% across the Company New structure focuses the business on accelerating revenue growth in the Canadian market TORONTO, February 11, 2020 – The Supreme Cannabis Company, Inc. (“Supreme Cannabis” or the “Company”) (TSX: FIRE) (OTCQX: […]

General Cannabis’ SevenFive Farms Acquisition Provides In-Roads to Colorado

February 7th, 2020 - Ryan Allway

Colorado cannabis sales hit $1 billion in total cannabis-related revenue in 2019, becoming the first state in the country to hit that milestone five years after legalization. In addition, Colorado has the highest per-person spending on cannabis at $280 per year, which is significantly higher than the $220 and $130 annual spend in Washington State […]

Supreme Cannabis 2020, A Simple Approach On The Path To Profitability

January 23rd, 2020 - Ryan Allway

Many expect 2020 to go down as the shakeout year for the Canadian cannabis industry; the year where winners will make their way to the top and companies with weak fundamentals will be ruled out. Of the potential winners, The Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) is one Canadian player that stands out with its […]

Supreme Cannabis Announces Leadership Transition as Company Accelerates Transformation into Premium Cannabis CPG Company

January 6th, 2020 - Ryan Allway

Supreme Cannabis Board Director and former President of Starbucks Coffee Canada, Colin Moore, appointed Interim President and CEO. Navdeep Dhaliwal departs Company, effective immediately. Interim CEO to leverage successful track record to accelerate growth and transformation strategy, while improving speed to market and rightsizing operating and capital spends. Search for new CEO to begin immediately. […]

Isracann Closer to Greenhouse Construction as Israel Cannabis Market Heats Up

December 10th, 2019 - Ash Stringer

Israel has long been recognized for its pioneering contributions to research in the medical cannabis field. Recently, the state made its commitment clear to develop the sector by issuing a white paper on the opportunity to invest in Israeli cannabis. That was followed by the largest medical-marijuana merger ever in the country, with Cannbit Pharmaceuticals […]

Canibrands Capitalizes on CBD with Deep Product Line & Celebrity Support

December 6th, 2019 - Ryan Allway
CaniBrands products

Cannabidiol, better known as CBD, has become one of the most popular wellness products in the United States over the past couple of years. BDS Analytics and Arcview Market Research expect CBD sales to grow at a 49% compound annual growth rate to surpass $20 billion by 2024—making up about half of the total cannabinoid […]

The Supreme Cannabis Company Launches New CBD Product as New Senior Executives Join the Team

December 4th, 2019 - Ash Stringer

2019 has been tough sledding for essentially every public company in the cannabis space. It’s not unlike other times over the last decade when high growth stocks, as they’re colloquially called, have followed large gains with sharp retractions. While unpleasant for market bulls, it is a normal and healthy part of a cycle, particularly for […]

The Two Areas Where Large-Scale Cannabis Farming is Legal in California

December 3rd, 2019 - Ash Stringer

Famously known for its vineyards, the rolling hills of Santa Barbara, California and, 200 miles to the north, the Salinas Valley, once the rose capital of the world, have transformed into new commerce hubs: cannabis. As the only areas of California currently allowing large-scale cannabis cultivation, companies looking to get an upper hand on market […]

The Yield Growth Corp. Keeps Growing Like a Weed…or a Mushroom

November 26th, 2019 - Ash Stringer

While some companies are scratching their heads about what to make of the brutal treatment cannabis stocks have felt this year, The Yield Growth Corp. (CSE: BOSS)(OTCQB: BOSQF) seems undaunted, expanding its cannabis business while rapidly emerging as a leading public company in the mushroom space. Click here to receive an investor deck and corporate […]

Strength in Numbers: The Name You Don’t Know in Cannabis, But Should…GreenStar Biosciences

November 20th, 2019 - Ash Stringer

Centene. Energy Transfer. Tech Data. Arrow Electronics. What do these companies have in common? They each generate over $40 billion a year in revenue and most people have never heard of any of them. Investors that have enjoyed triple-digit returns from all of them over the last decade probably don’t mind too much that the […]

Supreme’s 7ACRES Continues to Impress

November 14th, 2019 - Ash Stringer

2018 was a stellar year for cannabis advocates as the green rush of marijuana legalization swept the globe, including California, the world’s fifth biggest economy, legalizing recreational marijuana and Canada becoming the first G20 nation to do so; however, 2019 may go down – surprisingly – as the year of a cannabis shake-out. Despite retreating […]

CFN Media Releases New Interviews within Its Cannabis Funds Series

November 14th, 2019 - Ryan Allway

Watch exclusive video interviews of leading cannabis industry funds and investors profiling their investment strategies, portfolios and new objectives Santa Monica, California–(Newsfile Corp. – November 12, 2019) – CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the worldwide cannabis industry, today announced the release […]

Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at,, or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at and You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit:

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer